March 30, 1990
Three Colombians convicted of possessing 1,200 pounds of cocaine for sale in the largest drug bust in the history of the Glendale Police Department were sentenced Thursday to a combined 41 years in state prison. Superior Court Judge Gordon Ringer sentenced Adolfo Guevara, 28, to 19 years; Ferney Tavera, 25, to 12 years, and Luis Varcla, 26, to 10 years. Ana Agudelo, 72, also a Colombian, was placed on six months' probation, said Deputy Dist. Atty. Ellen Berk.
November 22, 1999 |
Imagine an anti-cancer drug that acts like a guided missile, seeking out a patient's malignant cells and then destroying them with microscopic radioactive warheads, while sparing the surrounding healthy tissue. Such an approach to battling cancer was first envisioned a quarter of a century ago with the discovery of a way to make large amounts of highly specific antibodies, natural substances that travel through the bloodstream and can seek out targets on the surface of tumors.
February 11, 1994 |
Former First Lady Jacqueline Kennedy Onassis has non-Hodgkin's lymphoma, a treatable form of cancer of the lymphatic system, and has been undergoing chemotherapy for about a month, the New York Times reported in today's editions. The paper said Onassis, 64, had not interrupted her personal routines or her duties as a book editor.
August 18, 2005 |
Genentech Inc., Swiss drug maker Roche Holding and Biogen Idec Inc. said they had completed their U.S. marketing application to expand use of their drug Rituxan to patients never before treated for non-Hodgkin's lymphoma. The popular medicine was approved in the United States in 1997 for patients with the low-grade form of that type of lymphoma who had failed to benefit from other standard therapies.
CALIFORNIA | LOCAL
June 3, 1996 |
Chris Beck was a typical 19-year-old college kid struggling to keep his grades up when he went to a doctor to have a couple of small bumps on his head examined. The doctor told him they were impacted hair follicles, nothing to worry about. So on Jan. 23, he had them surgically removed. The bumps turned out to be cancer, non-Hodgkin's lymphoma, a form of the disease that causes cells in the immune system to spin out of control, create tumors and dispatch them throughout the body.
October 21, 1998 |
Coulter Pharmaceutical Inc.'s Bexxar drug could be a breakthrough therapy for low-grade non-Hodgkin's lymphoma, said analysts whom the company briefed on late-stage clinical trials of the medication.